Lakewood-Amedex outlines Nu-3 clinical progress after Nasdaq listing Sep 21, 2026 08:03AM
Lakewood-Amedex Biotherapeutics CEO Issues Letter to Shareholders Highlighting Transformational Progress and Outlook for Nu-3 Sep 21, 2026 08:02AM